| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Hyeyoung Kim | |
| Min Hyun Kim | |||
| P2860 | cites work | SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells | Q24301843 |
| Sirtuin functions in health and disease | Q24303857 | ||
| Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function | Q24306243 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Glutamine as an immunonutrient | Q26853577 | ||
| From sirtuin biology to human diseases: an update | Q27022606 | ||
| Cell death: critical control points | Q28240722 | ||
| Co-expression of glutaminase K and L isoenzymes in human tumour cells | Q28288822 | ||
| Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells | Q28504783 | ||
| The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4 | Q28508613 | ||
| SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism | Q28587694 | ||
| The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction | Q29616653 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| p53 in health and disease | Q29619939 | ||
| Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer | Q33604129 | ||
| Glutamine addiction: a new therapeutic target in cancer | Q34050094 | ||
| p53: death star | Q34103258 | ||
| Apoptotic pathways: the roads to ruin | Q34753431 | ||
| Sorting out functions of sirtuins in cancer | Q34970771 | ||
| Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth | Q35458543 | ||
| Transcriptional activation by the Myc oncoprotein. | Q36451347 | ||
| p53 and its downstream proteins as molecular targets of cancer | Q36465471 | ||
| Physiological analysis of oncogenic K-ras | Q36498721 | ||
| Chemotherapy and dietary phytochemical agents | Q36516033 | ||
| Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. | Q36850905 | ||
| Sirt4: the glutamine gatekeeper | Q36852306 | ||
| Sirtuins: critical regulators at the crossroads between cancer and aging | Q36908428 | ||
| Cancer chemoprevention: a rapidly evolving field. | Q37003415 | ||
| K-ras as a target for lung cancer therapy | Q37180240 | ||
| Myc's broad reach | Q37299032 | ||
| MYC-induced cancer cell energy metabolism and therapeutic opportunities | Q37438881 | ||
| Rethinking the Warburg effect with Myc micromanaging glutamine metabolism | Q37677940 | ||
| Sirtuins and disease: the road ahead | Q37982713 | ||
| Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis | Q37986289 | ||
| The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation | Q39180488 | ||
| Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria | Q40013166 | ||
| Glutamine modulates LPS-induced IL-8 production through IkappaB/NF-kappaB in human fetal and adult intestinal epithelium. | Q40465533 | ||
| Myc and the cell cycle | Q41703353 | ||
| Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells | Q43237277 | ||
| Glutamine prevents DMBA-induced squamous cell cancer | Q43907608 | ||
| Anticancer activity of flavonol and flavan-3-ol rich extracts from Croton celtidifolius latex. | Q45588051 | ||
| The Journal of Biological Chemistry, Volume 249, 1974: Uptake and metabolism of plasma glutamine by the small intestine | Q49082366 | ||
| Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts. | Q53341827 | ||
| Approaches to prevention of epithelial cancer during the preneoplastic period | Q53591952 | ||
| Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine. | Q53606211 | ||
| p53 status and the efficacy of cancer therapy in vivo | Q72839445 | ||
| Mitochondrial glutathione depletion by glutamine in growing tumor cells | Q73153931 | ||
| [Long- and short-range strategies in cancer prevention] | Q83151368 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 221-226 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Journal of cancer prevention | Q26841879 |
| P1476 | title | Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells | |
| P478 | volume | 18 |
| Q41034804 | Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer |
| Q64245279 | CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis |
| Q64052476 | Effect of cold atmospheric plasma treatment on the metabolites of human leukemia cells |
| Q47095381 | Endogenous glutamine decrease is associated with pancreatic cancer progression. |
| Q92035048 | Ex vivo metabolite profiling of paediatric central nervous system tumours reveals prognostic markers |
| Q58197290 | Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells |
| Q36165662 | Low-mass-ion discriminant equation (LOME) for ovarian cancer screening |
| Q37665348 | Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis |
| Q42321596 | Oncogenic regulation of tumor metabolic reprogramming |
| Q41349258 | Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism |
| Q94564029 | Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer |
| Q37552285 | Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics |
| Q49182137 | Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies |
| Q39302506 | The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases |
| Q28069398 | Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy |
Search more.